___

• 1- WHO, Vaccines and Biologicals. Guideline for establishing or improving primary and intermediate vaccine stores, 2002. 2- Diminsky D, Moav N, Gorecki M, Barenholz Y. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 1999;18:3-17. 3- Boros CA, Hanlon M, Gold MS, Roberton DM. Storage at -3 degrees C for 24 hours alters the immunogenicity of pertussis vaccines. Vaccine 2001;19:3537-42. 4- Miller NC and Harris MF. Are childhood immunization programmes in Australia at risk? Investigation of the cold chain in the Northern Territory. Bull World Health Organ 1994;72:401- 8. 5- Guthridge SL and Miller NC. Cold chain in a hot climate. Aust N Z J Public Health 1997;20:657- 60. 6- Bass AG and Battersby A. Vaccine storage in cold climates: Europe to Central Asia [background paper]. March 16-20, 1998; Copenhagen, TechNet 1998. 7- Edstam JS, Dulmaa N, Tsendjav O, Dambasuren B, Densmaa B. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia. Prev Med. 2004;39:384-8. 8- Jeremijenko A, Kelly H, Sibthorpe B, Attewell R. Improving vaccine storage in general practice refrigerators. BMJ. 1996; 312:1651-2. 9- Lugosi L, Battersby A. Transport and storage of vaccines in Hungary: the first cold chain monitor study in Europe. Bull World Health Organ. 1990;68:431-9. 10- Nelson C. M, Wibisono H, Purwanto H, Mansyur I, Moniaga V, Widjaya A. Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. Bull World Health Organ 2004, 82:99-105. 11- USAID. Immunization essentials, a practical field guide. 2003 12- Conditioning ice packs. WHO. Accessed at July 19, 2006 at http://www.who.int/vaccinesccess/ vacman/transport/conditioningicepacks.htm 13- WHO, Department of Vaccines and other Biologicals. Temperature monitors for vaccines and the cold chain, Geneva 1999.